This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           August 12, 2015

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store



CHEMOTHERAPY
 

Ob/Gyn residents may be underprepared for advanced training
Medscape (Free login required)
Fellowship directors do not believe graduating residents are well prepared for training in the four accredited obstetrics/gynecology subspecialties, a survey has shown. Saketh R. Guntupalli, MD, from the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, and colleagues report the survey results in an article published online July 31 and in the September issue of Obstetrics & Gynecology.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




SGO NEWS


FDA to host Ovarian Cancer Endpoints Workshop
The FDA is hosting the “Ovarian Cancer Endpoints Workshop” in cooperation with SGO, AACR and ASCO from 8 a.m. to 5 p.m. Thursday Sept. 3, 2015, in Silver Spring, MD, or via streaming webcast. Read details in SGO Issues and register now.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


OVARIAN CANCER


Ovarian cancer not as fatal as previously thought, study finds
Medical News Today
Ovarian cancer is the fifth most common cause of cancer deaths among women in the U.S., according to the American Cancer Society. However, a new study published in the Journal of Obstetrics and Gynecology offers hope for women diagnosed with the disease; the 10-year survival rate is higher than previously thought.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


Why evidence from a randomized clinical trial for ovarian cancer treatment has limited value
Forbes (opinion)
The New York Times ran an article on patients not getting cancer care recommended by the NCI since 2006: “Effective Ovarian Cancer Treatment Is Underused, Study Finds.” Indeed, upon reading this news – and the JCO report on the trial – you might be persuaded that most women with advanced ovarian cancer are not receiving the best therapy. And you’d be right, but not only for the reasons cited in the Times.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ENDOMETRIAL CANCER


Birth control pill protects against endometrial cancer for decades
Medical News Today
A new study published in The Lancet Oncology claims the birth control pill offers long-term protection against endometrial cancer. Researchers say that over the past decade alone, the pill has prevented 200,000 cases of the disease in developed countries.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


INDUSTRY FUNDING


Drug companies quietly funnel funds to doctors
The Boston Globe
Fancy steak dinners, junkets at lush resorts, and cushy speaking gigs to promote new drugs have been on the wane since lawmakers forced drug companies to disclose most of the ways they steered lucrative perks and consulting fees to doctors. But critics say the stream of drug money to top physicians has flourished on a route that remains largely hidden: the continuing education programs that doctors must attend to keep their licenses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORCELLATION


Lawmakers ask GAO to investigate power morcellators
Medscape (Free login required)
Twelve members of Congress asked a federal watchdog agency last week to investigate why the U.S. Food and Drug Administration (FDA) took so long to warn that power morcellators may spread unseen cancers in the course of removing uterine fibroids. "Hundreds, if not thousands, of women in America are dead" because of these devices, the bipartisan group of lawmakers wrote in an Aug. 7 letter to the U.S. Government Accountability Office (GAO).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  Ovarian cancer updates from ASCO 2015:

Four prominent experts in ovarian cancer met in Chicago to provide perspectives related to progress made toward personalized therapy. More
 


BREAST CANCER


Shorter course of high-dose radiation therapy 'better for breast cancer patients'
Medical News Today
For women with early-stage breast cancer, a shorter course of radiation therapy at higher doses may be less toxic and lead to better life quality than a longer course at lower doses. This is according to two new studies published in JAMA Oncology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




HEALTH POLICY


Dying to live: Why is healthcare so valuable in the face of death?
Forbes (opinion)
Care near the end of life or for life-threatening illnesses is often highly valued by patients but fares poorly with past and recent valuation frameworks constructed by buyers of such care. This has recently become the source of much debate in cancer care, where treatments for metastatic disease may offer limited survival benefits at high costs. Traditional valuation frameworks, however, fail to account for the unique value dimensions in this type of care. Part of this is of course just buyers wanting lower prices, but there is also a fundamental lack of understanding of the value dimensions in this type of care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISSED AN ISSUE OF WOMEN'S CANCER NEWS?
Visit the SGO Women's Cancer News archive page.


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 5, 2015
July 29, 2015
July 22, 2015
July 15, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063